Screening for Proteinuria and Chronic Kidney Disease Risk Factors in Kinshasa:A World Kidney Day 2007 Study by Sumaili, Ernest K. et al.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Original Paper 
 Nephron Clin Pract 2008;110:c220–c228 
 DOI: 10.1159/000167869 
 Screening for Proteinuria and Chronic 
Kidney Disease Risk Factors in Kinshasa: 
A World Kidney Day 2007 Study 
 Ernest K. Sumaili a, d    Nazaire M. Nseka a    François B. Lepira a    
Jean Marie Krzesinski d    Jean Robert R. Makulo a    Justine B. Bukabau a    
Josée B. Nkoy b    Vieux M. Mokoli a    Murielle M. Longokolo a    
Julie A. Owandjalola a    Patrick K. Kayembe c 
 a  Nephrology Unit, University of Kinshasa,  b  Saint Joseph Hospital of Kinshasa and  c  Medical Epidemiology and 
Biostatistics Unit, School of Public Health, University of Kinshasa,  Kinshasa , Democratic Republic of Congo; 
 d  Division of Nephrology/Transplantation, University of Liège,  Liège , Belgium 
betes, 5 persons with hypertension, 4 subjects having meta-
bolic syndrome, 5 persons aged  6 72 years and 9 persons 
without any of the conditions mentioned above. Age, over-
weight and diabetes were the strongest factors associated 
with proteinuria.  Conclusions: This study indicates that pro-
teinuria and traditional risk factors for CKD are very preva-
lent in Kinshasa. Realistic policies to stem these conditions 
should be a public health priority. 
 Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 Chronic kidney disease (CKD) is a worldwide public 
health problem  [1] . To cope with this epidemic, commu-
nity-based prevention is a necessary strategy and must be 
based on education, early detection and effective man-
agement of CKD and its associated risk factors  [2] . In-
deed, screening programs are integral components of ex-
isting CKD prevention programs. These strategies have 
already shown promising results in both developed and 
developing countries  [3–5] .
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 Abstract 
 Background: Although screening programs for chronic kid-
ney disease (CKD) may be of great value, these programs are 
not yet implemented in the Democratic Republic of Congo. 
This study focused on proteinuria and examined its preva-
lence in terms of the number needed to screen for the dif-
ferent risk factors of CKD. Such knowledge would guide the 
utility of population screening to prevent end-stage renal 
disease.  Methods: A cross-sectional survey was conducted 
in Kinshasa on the Second World Kidney Day. A sample of 
3,018 subjects was interviewed and the following measure-
ments were performed: blood pressure, body mass index, 
glycemia and urine protein. Logistic regression analysis was 
used to identify determinants of proteinuria.  Results: The 
prevalence of proteinuria was 17.1% (95% CI 15.8–18.6). Oth-
er CKD risk factors identified were: hypertension, diabetes 
mellitus, obesity and metabolic syndrome. To identify 1 case 
of proteinuria, one would need to screen 4 persons with dia-
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 However, the effectiveness of the strategy will depend 
on local infrastructure, finances and organization  [6] . 
Unfortunately, many countries in sub-Saharan Africa in-
cluding the Democratic Republic of Congo (DRC) have 
low capacity and resources to accomplish this. In some of 
them, the health expenditure per capita does not exceed 
USD 10 per year  [7] , and this is clearly insufficient to ad-
dress the challenges posed by the double burden of infec-
tious and noncommunicable diseases (NCD), including 
CKD.
 In addition, the paucity of symptoms and signs in ear-
ly CKD leads to delays in its recognition  [8] . Thus, com-
munity strategies to reduce incidence of end-stage renal 
disease (ESRD) may need to integrate methods of screen-
ing and early intervention adapted to the ability of the 
local team and facilities. Proteinuria is a well-recognized 
predictor of ESRD and cardiovascular as well as all-cause 
mortality rates  [9, 10] . Furthermore, several studies sug-
gest that low grades of proteinuria or microalbuminuria 
might be associated with early CKD even in a nondia-
betic population  [10, 11] . Moreover, screening for protein-
uria often alerts the physician to the presence of CKD 
before changes in the glomerular filtration rate (GFR) be-
come apparent and even precede the diagnosis of hyper-
tension or diabetes  [12] . Therefore, determination of risk 
factors for the development of proteinuria might facilitate 
focused preventive and therapeutic tools to delay the pro-
gression of CKD. 
 Previous studies have suggested that markers for car-
diovascular disease are also risk factors for renal disease 
and proteinuria  [13, 14] . However, those studies were fo-
cused primarily on Caucasian, African-American and 
Asian populations  [14, 15] . Also, because Black Africans 
are at increasing risk of developing ESRD and because 
CKD epidemiology in sub-Saharan Africa differs from 
that observed in other regions  [16] , it is conceivable that 
risk factors for proteinuria and renal disease among Black 
Africans might be different. Reasons of these differences 
are unclear but might be due to genetic and environmen-
tal differences.
 Well-designed surveys taking benefit of the World 
Kidney Day (WKD) can serve as a framework for advo-
cacy and community mobilization as well as an opportu-
nity to offer voluntary mass screening to early detect 
CKD and its associated risk factors  [17] .
 In the present study, we took advantage of the 2007 
WKD to describe the prevalence of proteinuria and the 
number of subjects needed to screen to identify 1 person 
with proteinuria as well as to evaluate factors associated 
with proteinuria in the Congolese population.
 Material and Methods 
 Study Design and Recruitment of Participants 
 Adults living in Kinshasa, a city of about 10 million inhabi-
tants, were eligible for the 2007 WKD cross-sectional screening 
for CKD and associated risk factors if they were aged 12 years or 
older and if they were able to give oral informed consent. The 
population was informed about the study via community adver-
tisement (TV, radio, newspapers, posters and word-of-mouth) as 
well as through community and political leaders.
 Study Setting, Overview of Procedures and Data Collection 
 In order to get a large sample nonrepresentative of the adult 
population living in the city, study sites were selected arbitrarily 
in different quarters of the city. Those included the University of 
Kinshasa, the Pax private clinic near a very big bus station at Rond 
Point Ngaba (North), a secondary school, the Kabalo school in 
Kintambo (West), a church at Matonge, Saint Joseph, the central 
part of the city (Center) and a church at Kimbanseke, Saint Boni-
face (East). 
 The survey was conducted in March 2007 during 4 consecu-
tive Thursdays from 8 a.m. to 6 p.m. by 75 trained volunteers re-
cruited among medical doctors, laboratory technicians, nurses 
and medical students.
 The subsequent phases of this work are illustrated in  figure 1 . 
In brief, the campaign included the following steps: educational 
message about the kidney (role, diseases and risk factors), regis-
tration, recording of general information (family and personal 
medical history, lifestyle habits), urinalysis, physical examina-
tion, blood sugar analysis, interpretation of the results and man-
agement. 
 Knowing that 12.4% of adults have CKD of all stages in Kin-
shasa  [18] , approximately 3,129 subjects were needed to reach this 
prevalence with error estimate of 2%. Of an intended sample size 
of three thousand five hundred, 3,134 persons agreed to partici-
pate. Among them, 3,018, aged 12 years or more completed the 
interview and were physically examined. 
 Interviews collected information on demographic character-
istics, daily intake of salt and fruits and vegetables in the diet, 
smoking habit, alcohol consumption, indigenous herbal remedies 
use, birth weight knowledge and physical activity. The physical 
activity during the time of leisure was classified as activity (phys-
ical activity of at least 30 min/day or 4 h/week) and inactivity in 
the contrary case. Data about family and medical history of kid-
ney disease, hypertension, diabetes, obesity as well as current 
treatment were recorded. They were asked to collect a urine sam-
ple which was then used to detect proteins with urinary strips 
(Medi-Test Combi 9) by the readers trained for this purpose. Fe-
male subjects were instructed to void a random urine specimen, 
remote from menstrual periods. Proteinuria was defined as 1+ or 
greater. For subjects having leukocyturia or positive dipstick ni-
trite test, classification as having proteinuria required its confir-
mation after treatment with antibiotics.
 Body weight, height and waist/hip circumference were mea-
sured. Height was taken to the nearest 0.1 cm with a portable sta-
diometer (Seca) and weight was measured to the nearest 0.1 kg on 
a mechanical scale (Seca). 
 Thereafter, the subjects were allowed to relax for 5 min in a 
sitting position before determination of blood pressure. Blood 
pressure was measured twice in the right or left arm using an au-
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tomatic machine (Omron M 5-1) at heart level. Hypertension was 
defined by an average of systolic blood pressure  6 140 mm Hg or 
diastolic blood pressure  6 90 mm Hg and/or concomitant use of 
antihypertensive medications by self-report (known hyperten-
sive)  [19] . 
 The body mass index (BMI) was calculated from the measured 
height (in meters) and weight (in kilograms) and was categorized 
as not obese ( ! 25), overweight (25–29.9) or obese ( 6 30) according 
to the 2000 WHO criteria  [20] . Metabolic syndrome was defined 
simply as abdominal obesity (waist circumference  1 102 cm for 
males and  1 88 cm for females) associated with blood pressure 
 6 130/85 mm Hg and fasting glucose  6 110 mg/dl  [21] . 
 Fingertip blood (Ascensia Entrust glucometer; Bayer) for fast-
ing glucose or random glucose was also performed. The diagnosis 
of diabetes was confirmed after repeat testing on a subsequent 
week (fasting glucose values of  6 126 mg/dl) or a positive history 
of diabetes and/or concomitant use of antidiabetic medications by 
self-report (known diabetic)  [22] .
 Kidney damage was defined as the presence of  6 1+ protein 
(equivalent to  6 30 mg/dl). 
 Statistical Analysis 
 Results are presented as numbers, percentages or means  8 
SD. Two-sample Student’s t test and   2 test were used for com-
parison of means and proportions where appropriate. The crude 
(unadjusted) and adjusted odds ratios (OR) were estimated to as-
sess the relationship between the risk factors and kidney damage 
(proteinuria) using a stepwise logistic regression analysis. The ex-
posure variables included age, gender, smoking, alcohol con-
sumption, indigenous herbal remedies, birth weight knowledge, 
family history (diabetes, hypertension, obesity and kidney dis-
ease), diabetes, hypertension and BMI. All data analysis and cal-
culations except the   2 test were performed by using the standard 
statistical package (SPSS, version 13.0).   2 test was performed in 
the dialog box using Medcalc, version 9.1.01. The zero hypothesis 
was rejected at p  ! 0.05.
 All rules of confidentiality were complied with, including col-
lection of information and physical examination. The study pro-
tocol and related documents were approved by the provincial and 
national levels of the Ministry of Health. 
 Results 
 Characteristics of the Study Population 
 More than half (57.6%) of the examined subjects had 
at least 1 of the signs of NCD ( fig. 1 ).  Table 1 shows the 
sociodemographic characteristics of the participants. 
The age range was 12–85 years (mean 44.3  8 15.3, me-
dian 45). Some statistically significant differences be-
tween male and female subjects were observed. Female 
subjects were older (mean 46.5  8 14.8 vs. 42.8  8 15.5 
years, p  ! 0.001). Physical inactivity and a family history 
of obesity were more frequent among them than in male 
subjects. In contrast, proportions of those with low or 
high birth weight, smoking habit, herbal remedies use, 
high educational level and employment were more preva-
lent in male than in female subjects (p  ! 0.01).
 Prevalence of Proteinuria and Number Needed to 
Screen to Identify One Person with Findings 
 Proteinuria (regardless of kidney function) was de-
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measurements, ﬁngertip blood or conﬁrmatory test,
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n = 1,739 (57.6%)
Available for follow-up in healthcare (primary, secondary or tertiary)
Proteinuria (n = 516), HBP (n = 1,123), diabetes (n = 270)
and obesity (n = 325) associated or not
 Fig. 1. Illustration of the phases of the free 
mass screening of proteinuria and associ-
ated risk factors of CKD at the 2007 WKD 
(‘Are Your Kidneys OK’) in Kinshasa. 
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only 21 (4%) were aware of their condition. The frequen-
cy distribution of dipstick proteinuria without hematuria 
is given in  table 2 . Among subjects with proteinuria, 
15.3% (n = 463) of the total population exhibited isolated 
proteinuria and the remaining 1.7% (n = 53) of the study 
population had proteinuria with hematuria. Isolated he-
maturia, defined as dipstick hematuria  6 1+, was found 
in 3.8% (n = 114) of the total population.
 In addition, the prevalence of proteinuria among 
other CKD risk factors screened is shown in  figure 2 . 
Furthermore, the prevalence of various states of pro-
teinuria in 7 different target groups (whole population, 
diabetics, hypertensives, metabolic syndrome cases, 
obese, overweight subjects and persons without NCD) 
for 7 age categories (12–21, 22–31, 32-41, 42–51, 52-61, 
62-71 and  6 72 years of age) is displayed in  table 3 . The 
prevalence estimates are also presented as the number 
of persons one would need to screen (number needed
to screen to identify 1 participant with the constellation 
of findings specified in  table 3 ). Overall, proteinuria 
 becomes more prevalent with older age in most differ-
ent target groups and the number needed to screen is 
lower.
 Determinants of Proteinuria 
 Risk factors associated with proteinuria are summa-
rized in  table 4 . Diabetes mellitus (adjusted OR 1.3, 95% 
CI 1.02–1.8; p  ! 0.05), overweight (adjusted OR 1.2, 95% 
CI 1.02–1.6; p  ! 0.05) and increasing age (adjusted OR 1.4 
for over 50 years vs.  ! 50 years, 95% CI 1.1–1.7; p = 0.01) 
were   independent factors associated with proteinuria. 
The OR for proteinuria increased proportionately with 
age (data not shown). However, male gender, family and 
Table 1. Characteristics of the study population by gender
Clinical features Males (n = 1,767) Females (n = 1,239) p value
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Alcohol consumption currently 886 (50.1) 366 (29.5) <0.0001
Herbal remedies use currently
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Values expressed as numbers and percentages in parentheses or means 8 SD, as appropriate. Data from the 
2007 WKD (‘Are Your Kidneys OK’) in Kinshasa. 1 Low birth weight: <2.5 kg; high birth weight: ≥3.8 kg.
Table 2. Distribution of degree of proteinuria of study population 
(n = 3,018) 
Proteinuria n %
+1 (30 mg/dl) 449 14.8
+2 (100 mg/dl) 53 1.7
+3 (500 mg/dl) 14 0.4
All patients (≥+1) 516 17.1
Data from the 2007 WKD (‘Are Your Kidneys OK’) in Kin-
shasa.
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medical history of kidney disease, hypertension or diabe-
tes, smoking and herbal remedies use were not significant 
predictors for the presence of proteinuria in this study. 
 Discussion 
 A call to action on the 2007 WKD  [17] prompted us to 
identify that a significant number of the adult population 
of Kinshasa has proteinuria and other CKD risk factors 
such as hypertension, diabetes and/or obesity. This fact is 
well illustrated by our recent report of increasing number 
of CKD and associated risk factors in the general popula-
tion of Kinshasa  [18] .
 Over 15% of our study subjects had proteinuria. This 
value is much higher than the 11% found in Bolivia  [5] 
and the 8.7% in NHANES III  [3] , but lower than the 55, 
35 and 26% observed in Tiwi islanders  [23] , South Afri-
cans  [24] and among Zuni Indians  [25] , respectively. This 
0









 Fig. 2. Prevalence of proteinuria in non-NCD persons, hyperten-
sives, diabetics, metabolic syndrome subjects and participants 
 1 50 years. Data from the 2007 WKD (‘Are Your Kidneys OK’) in 
Kinshasa. 
Table 3. Prevalence of proteinuria in 7 study groups by age (in decades)
Age group, years





























































































































Values expressed as numbers and percentages in parentheses. NNS = Number needed to screen.
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discrepancy between studies may be due partly to various 
definitions (microalbuminuria vs. dipstick proteinuria) 
and criteria of selection (random vs. without random 
sample or/and high risk population vs. whole population) 
applied in each survey.
 We recognize that dipstick proteinuria has limited 
sensitivity and specificity  [26] . However, despite the fact 
that the present study used dipstick proteinuria, it is of 
great prognostic value. For example, screening with the 
urine dipstick test for proteinuria has been used success-
fully in Japan since 1972, targeting every child and work-
er, as well as since 1983 for every resident over 40 years 
old  [27] . Moreover, a survey undertaken in Okinawa after 
17 years of follow-up indicates that individuals with dip-
stick-positive proteinuria are at increased risk of develop-
ing CKD, in fact in proportion to the severity of protein-
uria  [28] . Sam et al.  [29] have demonstrated that trace 
dipstick proteinuria usually means microalbuminuria. 
Indeed, in their survey, a negative urinalysis for protein-
uria excluded microalbuminuria in 87% and proteinuria 
in 78% of cases. In addition, more recently, it has also be-
come apparent that dipstick proteinuria is more indica-
tive of microalbuminuria than macroalbuminuria  [30] . 
This is a fact because of the subjects that were trace, 1+ or 
2+ positive on a dipstick protein, 61, 71 and 41%, respec-
tively, had microalbuminuria, whereas only 1, 7 and 50%, 
respectively, had macroalbuminuria. It is likely that the 
majority of our cases that were positive for proteinuria in 
fact had microalbuminuria.
 In our study, 9 adults that do not have NCD need to be 
screened to identify 1 individual with proteinuria. This 
number decreases in certain subgroups, amounting to 4 
in diabetics, 5 in hypertensives, 4 in persons with meta-
bolic syndrome or 5 in persons  1 50 years. The NHANES 
III yielded similar results  [14] especially in the diabetic 
group. Yet, some differences exist between the 2 studies. 
The testing method for albuminuria was different. In ad-
dition, it is possible that the relatively low prevalence of 
albuminuria observed in their survey  [14] compared to 
ours results from the use of antihypertensive therapy 
(specifically, angiotensin-converting enzyme inhibitor 
and angiotensin receptor blocker use), which may reduce 
the number of patients with proteinuria. 
 In our present survey, diabetes, overweight and in-
creasing age were independently associated with the pres-
ence of proteinuria. Age is a recognized risk factor for 
renal disease  [31] . This is attributed partly to glomerular 
obsolescence and decreased renal vascular flow  [32] . 
Other factors associated with proteinuria in univariate 
but not in multivariate analysis in our study were hyper-
tension and metabolic syndrome. Several studies already 
demonstrated the relationship between hypertension as 
well as increasing BMI and proteinuria  [33] . For example, 
in prospective studies, such as the Multiple Risk Factor 
Intervention Trial (MRFIT), each 9-mm Hg increase in 
DBP was associated with an OR of 1.37 for the presence 
of dipstick-positive proteinuria  [34] . Plausible mecha-
nisms have focused on the elevation in the pressure trans-
mitted to glomeruli, which might result in sclerosis and 
proteinuria  [35] . Moreover, as reported by Chen et al.  [36] , 
metabolic syndrome is associated with higher risk for 
proteinuria. We have confirmed this. The exact mecha-
nism of this proteinuria/albuminuria-associated cardio-
vascular risk remains unknown, but might be due to en-
dothelial dysfunction  [37] . 
 However, some risk factors for proteinuria such as 
family and medical history of kidney disease, low birth 
weight and smoking, reported elsewhere  [15, 38] , were 
not observed in the present study. The lack of awareness 
of renal disease by both health workers and lay popula-
tion can partly explain this observation. Indeed, in our 
study, a little more than three quarters of the population 
does not know the localization, role or even name of the 
kidney in their mother tongue. In addition, most of our 
study population did not have birth certificates or knowl-
edge of their weight at birth. The reason why tobacco was 
Table 4. Determinants of proteinuria (univariate and multivariate analysis)
Risk factors
proteinuria (Medi-Test Combi 9)
Univariate analysis Multivariate analysis
OR 95% CI p value OR 95% CI p value
Hypertension vs. no 1.3 1.1–1.6 0.001 1.07 0.8–1.3 0.5
Diabetes vs. no 1.5 1.1–2.1 0.003 1.3 1.02–1.8 0.03
Overweight vs. no 1.3 1.1–1.7 0.005 1.2 1.02–1.6 0.03
Metabolic syndrome vs. no 1.5 1.03–2.2 0.03 1.4 0.9–2.1 0.1
Age <50 vs. ≥50 years 1.5 1.2–1.8 0.000 1.4 1.1–1.7 0.002
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not associated with proteinuria remains unclear and de-
serves further study. 
 Strength and Limitations of our Study 
 The strength of this study is that it includes a large 
sample of the general population of Kinshasa and that we 
used standardized methods of data collection. Already, 
by doing this study, we have improved awareness of CKD 
in the DRC and also addressed the fear of disease surveil-
lance formerly observed in this population. 
 However, there are some limitations and constraints 
that must be considered. First, a selection bias may exist 
because subjects who volunteered to participate in the 
screening program might be more likely to have the risk 
factors that we studied, including proteinuria. Second, as 
in any cross-sectional study, causation cannot be estab-
lished because the sequence of events between exposure 
and outcome is not defined. Third, because of lack of re-
sources, our study used simply dipstick methods to screen 
for proteinuria, which has detection limits as mentioned 
earlier  [26] . Indeed, common causes  [26, 39] for false pos-
itives by dipstick test may be seen in patients with gross 
hematuria, contamination with antiseptic agents 
(chlorhexidine, benzalkonium chloride), alkaline urine 
pH, highly concentrated urine and, conversely, false neg-
atives may occur in patients with dilute urine or in dis-
ease states in which predominant protein is not albumin 
(dipstick protein being sensitive only to albumin). In ad-
dition, proteinuria can occur transiently in response to 
hemodynamic stress (severe exercise, fever and convul-
sion), dehydration, cold exposure, congestion heart fail-
ure, urinary tract infection and during menstruation or 
pregnancy in women  [40] . It is also likely that some pos-
itive proteinuria among subjects with neither hyperten-
sion nor diabetes might be due to chronic glomerulone-
phritis which remains a major cause of ESRD in the DRC 
 [6, 41] . Furthermore, some cases of proteinuria in this 
study might be due to HIV or hepatitis B or C virus infec-
tions which are prevalent in this country  [41] . Yet, this 
study did not address the specific causes of proteinuria in 
individual subjects. Consequently, the only sign of CKD 
for those subjects at early stage is urinary abnormalities. 
 Fourth, except for proteinuria associated with pyuria, 
indicators of kidney damage were defined based on a sin-
gle measurement. In K/DOQI  [42] and K/DIGO  [2] 
guidelines, the definition of CKD requires the persis-
tence of kidney damage for at least 3 months. Also, stud-
ies based on NHANES III indicate that in repeated mea-
surement, only 63.2% of those with albuminuria would 
have persistently positive results  [3] . Hence, the single 
measurement of proteinuria in our study might overesti-
mate its prevalence. 
 Fifth, distribution of proteinuria across categories of 
estimated GFR could be informative and very useful. Un-
fortunately, we have not measured serum creatinine in 
this study due to pragmatic and economic reasons. How-
ever, proteinuria remains a good risk marker for develop-
ing ESRD  [27] . 
 To conclude, the present work, despite possible meth-
odological limitations, emphasizes that proteinuria and 
CKD risk factors such as hypertension, diabetes and obe-
sity are highly prevalent in Kinshasa, while awareness of 
NCD is very low. This study confirms diabetes, over-
weight and age as the strongest independent risk factors 
associated with proteinuria. Also, prevalence of protein-
uria among subjects with neither diabetes nor hyperten-
sion is high as in Japan  [27] but not in Caucasian popula-
tions. If confirmed, these data support the idea that an-
nual urinalysis screening for the whole population in the 
DRC might be cost-effective. This is in contrast to the re-
port of Boulware et al.  [43] who affirm that annual screen-
ing for proteinuria in US adults was not cost-effective be-
cause the prevalence of proteinuria was very low. Fur-
thermore, urinary albumin and creatinine ratio testing 
as well as microalbuminuria are more expensive than 
dipstick proteinuria. Therefore, urine dipstick test for 
proteinuria is suitable as a first step for most countries or 
races that have a high prevalence of proteinuria such as 
the DRC. Further studies to assess the performance of 
dipstick proteinuria as well as its cost-effectiveness anal-
ysis and including estimated GFR in this country are 
needed to develop adapted preventive strategies. This tar-
geted prevention strategy could result in the reduction of 
cardiovascular events as well as the alarming incidence 
of ESRD.
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